Clinical Trial Update: PR-0164 First in Human Clinical Trial of the PAVmed PortIO Intraosseous Infusion System [NA]

View source ↗

Summary

This update announces the completion of the first-in-human trial of the PortIO intraosseous infusion system by PAVmed, evaluated in chronic kidney disease patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• PortIO intraosseous infusion system

Snippet

Sponsor: PAVmed Inc. | Conditions: Chronic Kidney Disease stage3, Chronic Kidney Disease stage4 | NA | Status: COMPLETED